Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2401 to 2450 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 6 (ec 2.7.1.37) (s6k-alpha 6) (90 kda ribosomal protein s6 kinase 6) (p90-rsk 6) (ribosomal s6 kinase 4) (rsk-4) (pp90rsk4). [source:swissprot;acc:q9uk32]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1383\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
234\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6410.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5181.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.23728\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
235\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ribosome biogenesis regulatory protein homolog. [source:swissprot;acc:q15050]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
315\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17896.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21370.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ribulose-5-phosphate-3-epimerase; ribulose 5-phosphate 3-epimerase. [source:refseq;acc:nm\_006916]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1484\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5775.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5372.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07501\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 20. [source:refseq;acc:nm\_019592]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1683\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5419.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06908\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 25 (ec 6.3.2.-). [source:swissprot;acc:q96bh1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1931\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9367.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9946.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06176\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 3. [source:refseq;acc:nm\_006315]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2763\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 38. [source:refseq;acc:nm\_022781]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
866\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 4. [source:swissprot;acc:p78317]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3189\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 40; 95 kda retinoblastoma protein binding protein; likely ortholog of rat staring. [source:refseq;acc:nm\_014771]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1684\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5419.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06908\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ring finger protein 44. [source:refseq;acc:nm\_014901]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
864\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rio kinase 1 isoform 1; ad034 protein. [source:refseq;acc:nm\_031480]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2585\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna (guanine-7-) methyltransferase. [source:refseq;acc:nm\_003799]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1476\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6355.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5910.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1960\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5777.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5448.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06039\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna polymerase i associated factor 53. [source:refseq;acc:nm\_022490]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2500\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3705.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3804.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02685\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2678\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7741.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7780.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00515\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna polymerase ii subunit 5-mediating protein (rpb5-mediating protein). [source:swissprot;acc:o94763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1886\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6195.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5826\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06342\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna, u transporter 1; snurportin-1. [source:refseq;acc:nm\_005701]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2438\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7384.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7139.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03443\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein 10 (rna binding motif protein 10) (dxs8237e). [source:swissprot;acc:p98175]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2200\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5326.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5076.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04916\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein 5 (rna binding motif protein 5) (putative tumor suppressor luca15) (g15 protein). [source:swissprot;acc:p52756]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2207\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein 8a (rna binding motif protein 8a) (ribonucleoprotein rbm8a) (rna-binding protein y14) (binder of ovca1- 1) (bov-1). [source:swissprot;acc:q9y5s9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2996\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein 9 (rna binding motif protein 9) (hexaribonucleotide binding protein 2) (repressor of tamoxifen transcriptional activity). [source:swissprot;acc:o43251]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2113\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6092.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5776.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0547\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2640\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5395.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5339.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01052\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein with multiple splicing (rbp-ms). [source:swissprot;acc:q93062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2247\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6092.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5819.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04701\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
182\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29051\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding region containing protein 1 (hsrnaseb) (ssdna binding protein seb4) (cll-associated antigen kw-5). [source:swissprot;acc:q9h0z9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2184\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6132.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5838.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05042\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rna-binding region containing protein 2 (hepatocellular carcinoma protein 1) (splicing factor hcc1). [source:swissprot;acc:q14498]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1040\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5421.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rod1 regulator of differentiation 1; fission yeast differentiation regulator; regulator of differentiation (in s. pombi) 1; regulator of differentiation (in s. pombe) 1. [source:refseq;acc:nm\_005156]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2280\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rp42 homolog; squamous cell carcinoma-related oncogene. [source:refseq;acc:nm\_020640]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1108\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5283.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4846.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 1 (core-binding factor, alpha 2 subunit) (cbf-alpha 2) (acute myeloid leukemia 1 protein) (oncogene aml-1) (polyomavirus enhancer binding protein 2 alpha b subunit) (pebp2-alpha b) (pea2-alpha b) (sl3-3 enhancer factor 1 alpha b subunit) (sl3/akv core-binding factor alpha b subunit). [source:swissprot;acc:q01196]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2877\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2692\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4095.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4113.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
runt-related transcription factor 3 (core-binding factor, alpha 3 subunit) (cbf-alpha 3) (acute myeloid leukemia 2 protein) (oncogene aml-2) (polyomavirus enhancer binding protein 2 alpha c subunit) (pebp2-alpha c) (pea2-alpha c) (sl3-3 enhancer factor 1 alpha c subunit) (sl3/akv core-binding factor alpha c subunit). [source:swissprot;acc:q13761]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3208\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1895\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6252.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5882.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.063\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ruvb-like 2 (ec 3.6.1.-) (48-kda tata box-binding protein-interacting protein) (48-kda tbp-interacting protein) (tip49b) (repressing pontin 52) (reptin 52) (51 kda erythrocyte cytosolic protein) (ecp-51) (tip60-associated protein 54-beta) (tap54-beta) (cgi-46). [source:swissprot;acc:q9y230]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1899\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6149.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5786.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
390\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
rwd domain containing 1; ptd013 protein; cgi-24 protein. [source:refseq;acc:nm\_015952]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3073\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1034\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6732.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6152.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09414\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1027\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6700.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6123.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3225.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2353.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3705\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4301.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3729.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
144\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4362.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3349.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 1 (zinc finger protein sall1) (spalt-like transcription factor 1) (hsal1). [source:swissprot;acc:q9nsc2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2286\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 2 (zinc finger protein sall2) (hsal2). [source:swissprot;acc:q9y467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2276\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.69\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 3 (zinc finger protein sall3) (hsall3). [source:swissprot;acc:q9bxa9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2277\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.72\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
sal-like protein 4 (zinc finger protein sall4). [source:swissprot;acc:q9ujq4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2287\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.7\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
salivary proline-rich protein po (allele k) [contains: peptide p-d] (fragment). [source:swissprot;acc:p10162]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1921\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6652.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6262.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0623\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sam domain and hd domain-containing protein 1 (dendritic cell-derived ifng-induced protein) (dcip) (monocyte protein 5) (mop-5). [source:swissprot;acc:q9y3z3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3124\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
736\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/